167 related articles for article (PubMed ID: 27164530)
21. [Paraneoplastic neurological syndromes].
Antoine JC; Camdessanché JP
Presse Med; 2007 Oct; 36(10 Pt 2):1418-26. PubMed ID: 17399944
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and management of paraneoplastic neurological syndromes].
Saji E; Kawachi I; Nishizawa M
Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
24. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.
Candler PM; Hart PE; Barnett M; Weil R; Rees JH
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1411-5. PubMed ID: 15377687
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report.
Nanni L; Broccoli A; Nanni C; Argnani L; Cavo M; Zinzani PL
Leuk Lymphoma; 2018 Dec; 59(12):2990-2993. PubMed ID: 29616869
[No Abstract] [Full Text] [Related]
26. Paraneoplastic Neurologic Symptoms in a Pediatric Patient with Hodgkin Lymphoma.
Baniel CC; Donaldson SS; Aftandilian C; Hiniker SM
Cancer Invest; 2021 Feb; 39(2):159-162. PubMed ID: 33191790
[TBL] [Abstract][Full Text] [Related]
27. Incidence and spectrum of paraneoplastic neurological syndromes: single center study.
Kanikannan MA; Sirisha Y; Uppin MS; Jabeen SA; Kandadai RM; Sundaram C; Raghunadharao D; Borgohain R
J Neurooncol; 2015 Oct; 125(1):197-206. PubMed ID: 26307447
[TBL] [Abstract][Full Text] [Related]
28. Two cases of pseudo-achalasia with lung cancer: Case report and short literature review.
Hirano T; Miyauchi E; Inoue A; Igusa R; Chiba S; Sakamoto K; Sugiura H; Kikuchi T; Ichinose M
Respir Investig; 2016 Nov; 54(6):494-499. PubMed ID: 27886865
[TBL] [Abstract][Full Text] [Related]
29. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
30. Advances in paraneoplastic neurological syndromes.
Honnorat J; Cartalat-Carel S
Curr Opin Oncol; 2004 Nov; 16(6):614-20. PubMed ID: 15627026
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Chatterjee M; Hurley LC; Tainsky MA
Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
[TBL] [Abstract][Full Text] [Related]
32. Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.
Matsuhisa A; Toriihara A; Kubota K; Makino T; Mizusawa H; Shibuya H
Clin Nucl Med; 2012 Jan; 37(1):39-43. PubMed ID: 22157026
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
34. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
35. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
36. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
Patel RR; Subramaniam RM; Mandrekar JN; Hammack JE; Lowe VJ; Jett JR
Mayo Clin Proc; 2008 Aug; 83(8):917-22. PubMed ID: 18674476
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
[TBL] [Abstract][Full Text] [Related]
38. Paraneoplastic immune-mediated neurological effects of systemic cancers.
Sioka C; Fotopoulos A; Kyritsis AP
Expert Rev Clin Immunol; 2014 May; 10(5):621-30. PubMed ID: 24665890
[TBL] [Abstract][Full Text] [Related]
39. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
40. The immunopathogenesis of paraneoplastic neurological syndromes.
Sutton I; Winer JB
Clin Sci (Lond); 2002 May; 102(5):475-86. PubMed ID: 11980564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
